drugset / Trial / NCT00548938
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and efficacy of the combination of Gliadel wafers plus surgery and limited field radiation therapy with concomitant temozolomide followed by temozolomide given at an extended dose schedule (metronomic schedule) in patients undergoing initial surgery for newly-diagnosed high grade glioma.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gliadel Wafer | Unknown | — | Other |
| Subject | Temozolomide | Small molecule | 75 mg/m2 | — |